Table of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
6. Global Blepharitis Market, by Type
6.1 Introduction
6.2 Anterior Blepharitis
6.2.1 Market Estimates & Forecast, 2020โ2027
6.3 Posterior Blepharitis
6.3.1 Market Estimates & Forecast, 2020โ2027
6.4 Mixed Blepharitis
6.4.1 Market Estimates & Forecast, 2020โ2027
7. Global Blepharitis Market, by Diagnosis
7.1 Introduction
7.2 Physical Examination
7.2.1 Market Estimates & Forecast, 2020โ2027
7.3 Comprehensive Eye Examination
7.3.1 Market Estimates & Forecast, 2020โ2027
7.4 Others
7.4.1 Market Estimates & Forecast, 2020โ2027
8. Global Blepharitis Market, by Treatment
8.1 Introduction
8.2 Eye Cleansers
8.2.4 Market Estimates & Forecast, 2020โ2027
8.3 Artificial Tears
8.3.1.1 Market Estimates & Forecast, 2020โ2027
8.4 Antibiotic Therapy
8.4.1 Topical Antibiotic Therapy
8.4.2 Oral Antibiotic Therapy
8.4.3 Market Estimates & Forecast, 2020โ2027
9. Global Blepharitis Market, by End-User
9.1 Introduction
9.2 Hospitals
9.2.1 Market Estimates & Forecast, 2020โ2027
9.3 Specialty Centers
9.3.1 Market Estimates & Forecast, 2020โ2027
9.4 Others
9.4.1 Market Estimates & Forecast, 2020โ2027
10 Global Blepharitis Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K.
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
11 Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
12 Company Profiles
12.1 Scope Ophthalmics Ltd
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials
12.1.4 SWOT Analysis
12.2 NovaBay Pharmaceuticals, Inc.
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Thea Pharmaceuticals Limited
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Perrigo Laboratories
12.4.1 Company Overview
12.4.2 Product/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Merck & Co.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.6 Galderma S.A.
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.7 Novartis AG
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Others
13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Pharmaceutical Industry
14 Appendix
LIST OF TABLES
Table 1 Blepharitis Industry Synopsis, 2020โ2027
Table 2 Global Blepharitis Market Estimates and Forecast, 2020โ2027, (USD Million)
Table 3 Global Blepharitis Market, by Region, 2020โ2027, (USD Million)
Table 5 Global Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 6 Global Blepharitis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 7 Global Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 8 North America Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 9 North America Blepharitis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 10 North America Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 11 US Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 12 US Blepharitis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 13 US Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 14 Canada Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 15 Canada Blepharitis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 16 Canada Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 17 South America Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 18 South America Blepharitis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 19 South America Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 20 Europe Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 21 Europe Blepharitis Market, by Diagnosis, 2020โ2027, (USD Million)
Table 22 Europe Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 23 Western Europe Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 24 Western Europe Blepharitis Market, by diagnosis, 2020โ2027, (USD Million)
Table 25 Western Europe Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 26 Eastern Europe Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 27 Eastern Europe Blepharitis Market, by diagnosis, 2020โ2027, (USD Million)
Table 28 Eastern Europe Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 29 Asia Pacific Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 30 Asia Pacific Blepharitis Market, by diagnosis, 2020โ2027, (USD Million)
Table 31 Asia Pacific Blepharitis Market, by End-User, 2020โ2027, (USD Million)
Table 32 Middle East & Africa Blepharitis Market, by Treatment, 2020โ2027, (USD Million)
Table 33 Middle East & Africa Blepharitis Market, by diagnoses, 2020โ2027, (USD Million)
Table 34 Middle East & Africa Blepharitis Market, by End-User, 2020โ2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Blepharitis Market
Figure 3 Segmentation Market Dynamics for Blepharitis Market
Figure 4 Global Blepharitis Market Share, by Treatment 2020
Figure 5 Global Blepharitis Market Share, by Diagnosis 2020
Figure 6 Global Blepharitis Market Share, by End-User, 2020
Figure 7 Global Blepharitis Market Share, by Region, 2020
Figure 8 North America Blepharitis Market Share, by Country, 2020
Figure 9 Europe Blepharitis Market Share, by Country, 2020
Figure 10 Asia Pacific Blepharitis Market Share, by Country, 2020
Figure 11 Middle East & Africa Blepharitis Market Share, by Country, 2020
Figure 12 Global Blepharitis Market: Company Share Analysis, 2020 (%)
Figure 13 NovaBay Pharmaceuticals, Inc: Key Financials
Figure 14 NovaBay Pharmaceuticals, Inc: Segmental Revenue
Figure 16 NovaBay Pharmaceuticals, Inc: Geographical Revenue
Figure 17 Scope Ophthalmics Ltd.: Key Financials
Figure 18 Scope Ophthalmics Ltd.: Segmental Revenue
Figure 19 Scope Ophthalmics Ltd.: Geographical Revenue
Figure 20 Thea Pharmaceuticals Limited: Key Financials
Figure 21 Thea Pharmaceuticals Limited: Segmental Revenue
Figure 22 Thea Pharmaceuticals Limited: Geographical Revenue
Figure 23 Novartis AG: Key Financials
Figure 24 Novartis AG: Segmental Revenue
Figure 25 Novartis AG: Geographical Revenue
Figure 26 Perrigo Laboratories: Key Financials
Figure 27 Perrigo Laboratories: Segmental Revenue
Figure 28 Perrigo Laboratories. Geographical Revenue
Figure 29 Ardelyx, Inc.: Key Financials
Figure 30 Ardelyx, Inc.: Segmental Revenue
Figure 31 Ardelyx, Inc.: Geographical Revenue
Figure 32 Novartis AG. Key Financials
Figure 33 Novartis AG. Segmental Revenue
Figure 34 Novartis AG. Geographical Revenue